Skip to main content

Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial

Publication ,  Conference
Guimaraes, P; Lopes, RD; Stevens, SR; Green, JB; McGuire, DK; Holman, RR; Peterson, ED
Published in: CIRCULATION
November 14, 2017

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 14, 2017

Volume

136

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guimaraes, P., Lopes, R. D., Stevens, S. R., Green, J. B., McGuire, D. K., Holman, R. R., & Peterson, E. D. (2017). Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial. In CIRCULATION (Vol. 136).
Guimaraes, Patricia, Renato D. Lopes, Susanna R. Stevens, Jennifer B. Green, Darren K. McGuire, Rury R. Holman, and Eric D. Peterson. “Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial.” In CIRCULATION, Vol. 136, 2017.

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 14, 2017

Volume

136

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology